The DOI matches its Crossref record; 108 of the 108 references it cites were found in a registry or an index.
Molecules Great and Small: The Complement System
Open accessAbstract
The complement cascade, traditionally considered an effector arm of innate immunity required for host defense against pathogens, is now recognized as a crucial pathogenic mediator of various kidney diseases. Complement components produced by the liver and circulating in the plasma undergo activation through the classical and/or mannose-binding lectin pathways to mediate anti-HLA antibody-initiated kidney transplant rejection and autoantibody-initiated GN, the latter including membranous glomerulopathy, antiglomerular basement membrane disease, and lupus nephritis. Inherited and/or acquired abnormalities of complement regulators, which requisitely limit restraint on alternative pathway complement activation, contribute to the pathogenesis of the C3 nephropathies and atypical hemolytic uremic syndrome. Increasing evidence links complement produced by endothelial cells and/or tubular cells to the pathogenesis of kidney ischemia-reperfusion injury and progressive kidney fibrosis. Data emerging since the mid-2000s additionally show that immune cells, including T cells and antigen-presenting cells, produce alternative pathway complement components during cognate interactions. The subsequent local complement activation yields production of the anaphylatoxins C3a and C5a, which bind to their respective receptors (C3aR and C5aR) on both partners to augment effector T-cell proliferation and survival, while simultaneously inhibiting regulatory T-cell induction and function. This immune cell-derived complement enhances pathogenic alloreactive T-cell immunity that results in transplant rejection and likely contributes to the pathogenesis of other T cell-mediated kidney diseases. C5a/C5aR ligations on neutrophils have additionally been shown to contribute to vascular inflammation in models of ANCA-mediated renal vasculitis. New translational immunology efforts along with the development of pharmacologic agents that block human complement components and receptors now permit testing of the intriguing concept that targeting complement in patients with an assortment of kidney diseases has the potential to abrogate disease progression and improve patient health.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regulatory T Cells and Immune Tolerance
Sakaguchi, S., Yamaguchi, T., Nomura, T., & Ono, M. (2008) · Cell · doi:10.1016/j.cell.2008.05.009 · Cited by 5,325
Differential Diagnosis of Glomerular Disease: A Systematic and Inclusive Approach
Hebert, L. A., Parikh, S., Prosek, J., Nadasdy, T., & Rovin, B. H. (2013) · American Journal of Nephrology · doi:10.1159/000354390 · Cited by 4,376
Complement: a key system for immune surveillance and homeostasis
Ricklin, D., Hajishengallis, G., Yang, K., & Lambris, J. D. (2010) · Nature Immunology · doi:10.1038/ni.1923 · Cited by 3,654 · cited 2×
“Regulation Complement activation must be physiologically restrained to limit damage to self-cells (4).”
BackgroundM-Type Phospholipase A 2 Receptor as Target Antigen in Idiopathic Membranous Nephropathy
Beck, L. H., Bonegio, R. G. B., Lambeau, G., Beck, D. M., Powell, D. W., Cummins, T. D., Klein, J. B., & Salant, D. J. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810457 · Cited by 2,347
Non-Transgenic Mouse Models of Kidney Disease
Rabe, M., & Schaefer, F. (2016) · Nephron · doi:10.1159/000445171 · Cited by 1,922
Terminal Complement Inhibitor Eculizumab in Atypical Hemolytic–Uremic Syndrome
Legendre, C. M., Licht, C., Muus, P., Greenbaum, L. A., Babu, S., Bedrosian, C., Bingham, C., Cohen, D. J., Delmas, Y., Douglas, K., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1208981 · Cited by 1,586
Significance of the Positive Crossmatch Test in Kidney Transplantation
Patel, R., & Terasaki, P. I. (1969) · New England Journal of Medicine · doi:10.1056/nejm196904032801401 · Cited by 1,508
Atypical Hemolytic–Uremic Syndrome
Noris, M., & Remuzzi, G. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0902814 · Cited by 1,338
The Complement Inhibitor Eculizumab in Paroxysmal Nocturnal Hemoglobinuria
Hillmen, P., Young, N. S., Schubert, J., Brodsky, R. A., Socié, G., Muus, P., Röth, A., Szer, J., Elebute, M. O., Nakamura, R., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa061648 · Cited by 1,303
Complement regulators and inhibitory proteins
Zipfel, P. F., & Skerka, C. (2009) · Nature Reviews Immunology · doi:10.1038/nri2620 · Cited by 1,264
C3d of complement as a molecular adjuvant: Bridging innate and acquired immunity
Dempsey, P. W., Allison, M. E. D., Akkaraju, S., Goodnow, C. C., & Fearon, D. T. (1996) · Science · doi:10.1126/science.271.5247.348 · Cited by 1,197
ROLE OF C5A IN INFLAMMATORY RESPONSES
Guo, R.-F., & Ward, P. A. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115835 · Cited by 1,021
Complement-Binding Anti-HLA Antibodies and Kidney-Allograft Survival
Loupy, A., Lefaucheur, C., Vernerey, D., Prugger, C., van Huyen, J.-P. D., Mooney, N., Suberbielle, C., Frémeaux-Bacchi, V., Méjean, A., Desgrandchamps, F., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1302506 · Cited by 852
Delayed Graft Function in the Kidney Transplant
Siedlecki, A., Irish, W., & Brennan, D. C. (2011) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2011.03754.x · Cited by 817
Complement Is Activated by IgG Hexamers Assembled at the Cell Surface
Diebolder, C. A., Beurskens, F. J., de Jong, R. N., Koning, R. I., Strumane, K., Lindorfer, M. A., Voorhorst, M., Ugurlar, D., Rosati, S., Heck, A. J. R., et al. (2014) · Science · doi:10.1126/science.1248943 · Cited by 796
The role of the anaphylatoxins in health and disease
Klos, A., Tenner, A. J., Johswich, K.-O., Ager, R. R., Reis, E. S., & Köhl, J. (2009) · Molecular Immunology · doi:10.1016/j.molimm.2009.04.027 · Cited by 730
Uncoupling of Immune Complex Formation and Kidney Damage in Autoimmune Glomerulonephritis
Clynes, R., Dumitru, C., & Ravetch, J. V. (1998) · Science · doi:10.1126/science.279.5353.1052 · Cited by 625
Activation of human CD4+ cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype
Kemper, C., Chan, A. C., Green, J. M., Brett, K. A., Murphy, K. M., & Atkinson, J. P. (2003) · Nature · doi:10.1038/nature01315 · Cited by 587
Liszewski, M. K., Kolev, M., Le Friec, G., Leung, M., Bertram, P. G., Fara, A. F., Subias, M., Pickering, M. C., Drouet, C., Meri, S., et al. (2013) · Immunity · doi:10.1016/j.immuni.2013.10.018 · Cited by 582
Strainic, M. G., Liu, J., Huang, D., An, F., Lalli, P. N., Muqim, N., Shapiro, V. S., Dubyak, G. R., Heeger, P. S., & Medof, M. E. (2008) · Immunity · doi:10.1016/j.immuni.2008.02.001 · Cited by 580
Self-citationXiao, H., Schreiber, A., Heeringa, P., Falk, R. J., & Jennette, J. C. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.060573 · Cited by 579
Stegall, M. D., Diwan, T., Raghavaiah, S., Cornell, L. D., Burns, J., Dean, P. G., Cosio, F. G., Gandhi, M. J., Kremers, W., & Gloor, J. M. (2011) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2011.03757.x · Cited by 577
Medof, M. E., Kinoshita, T., & Nussenzweig, V (1984) · The Journal of experimental medicine · doi:10.1084/jem.160.5.1558 · Cited by 561
Local synthesis of complement component C3 regulates acute renal transplant rejection
Pratt, J. R., Basheer, S. A., & Sacks, S. H. (2002) · Nature Medicine · doi:10.1038/nm0602-582 · Cited by 534
Sahu, A., & Lambris, J. D. (2001) · Immunological Reviews · doi:10.1034/j.1600-065x.2001.1800103.x · Cited by 525
Pickering, M. C., Cook, H. T., Warren, J., Bygrave, A. E., Moss, J., Walport, M. J., & Botto, M. (2002) · Nature Genetics · doi:10.1038/ng912 · Cited by 518
COLLINS, A. B., SCHNEEBERGER, E. E., PASCUAL, M. A., SAIDMAN, S. L., WILLIAMS, W. W., TOLKOFF-RUBIN, N., COSIMI, A. B., & COLVIN, R. B. (1999) · Journal of the American Society of Nephrology · doi:10.1681/asn.v10102208 · Cited by 515
Properdin: binding to C3b and stabilization of the C3b-dependent C3 convertase.
Fearon, D. T., & Austen, K. F. (1975) · The Journal of experimental medicine · doi:10.1084/jem.142.4.856 · Cited by 481
Identification of the Goodpasture antigen as the alpha 3(IV) chain of collagen IV.
Saus, J., Wieslander, J., Langeveld, J. P., Quinones, S., & Hudson, B. G. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)37714-7 · Cited by 459
C5a Receptor Mediates Neutrophil Activation and ANCA-Induced Glomerulonephritis
Schreiber, A., Xiao, H., Jennette, J. C., Schneider, W., Luft, F. C., & Kettritz, R. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008050497 · Cited by 451
de Jorge, E. G., Harris, C. L., Esparza-Gordillo, J., Carreras, L., Arranz, E. A., Garrido, C. A., López-Trascasa, M., Sánchez-Corral, P., Morgan, B. P., & de Córdoba, S. R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603420103 · Cited by 447
A ROLE OF POLYMORPHONUCLEAR LEUKOCYTES AND COMPLEMENT IN NEPHROTOXIC NEPHRITIS
Cochrane, C. G., Unanue, E. R., & Dixon, F. J. (1965) · The Journal of Experimental Medicine · doi:10.1084/jem.122.1.99 · Cited by 419
ROLE OF COMPLEMENT IN INDUCTION OF ANTIBODY PRODUCTION IN VIVO
Pepys, M. B. (1974) · The Journal of Experimental Medicine · doi:10.1084/jem.140.1.126 · Cited by 356
C5a Receptor (CD88) Blockade Protects against MPO-ANCA GN
Xiao, H., Dairaghi, D. J., Powers, J. P., Ertl, L. S., Baumgart, T., Wang, Y., Seitz, L. C., Penfold, M. E. T., Gan, L., Hu, P., et al. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013020143 · Cited by 353
Atypical Hemolytic Uremic Syndrome
Kavanagh, D., Goodship, T. H., & Richards, A. (2013) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2013.08.003 · Cited by 348
Lachmann, N., Terasaki, P. I., Budde, K., Liefeldt, L., Kahl, A., Reinke, P., Pratschke, J., Rudolph, B., Schmidt, D., Salama, A., et al. (2009) · Transplantation · doi:10.1097/tp.0b013e3181a44206 · Cited by 344
Wang, Y., Hu, Q., Madri, J. A., Rollins, S. A., Chodera, A., & Matis, L. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.16.8563 · Cited by 336
Locke, J. E., Magro, C. M., Singer, A. L., Segev, D. L., Haas, M., Hillel, A. T., King, K. E., Kraus, E., Lees, L. M., Melacon, J. K., et al. (2009) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2008.02451.x · Cited by 319
Strainic, M. G., Shevach, E. M., An, F., Lin, F., & Medof, M. E. (2013) · Nature Immunology · doi:10.1038/ni.2499 · Cited by 302
Mechanisms and Treatment of CKD
Ruggenenti, P., Cravedi, P., & Remuzzi, G. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2012040390 · Cited by 286
Decay-accelerating factor modulates induction of T cell immunity
Heeger, P. S., Lalli, P. N., Lin, F., Valujskikh, A., Liu, J., Muqim, N., Xu, Y., & Medof, M. E. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041967 · Cited by 286
Self-citationSpitzer, D., Mitchell, L. M., Atkinson, J. P., & Hourcade, D. E. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.4.2600 · Cited by 280
Pickering, M. C., de Jorge, E. G., Martinez-Barricarte, R., Recalde, S., Garcia-Layana, A., Rose, K. L., Moss, J., Walport, M. J., Cook, H. T., de Córdoba, S. R., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070301 · Cited by 278
Lalli, P. N., Strainic, M. G., Yang, M., Lin, F., Medof, M. E., & Heeger, P. S. (2008) · Blood · doi:10.1182/blood-2008-04-151068 · Cited by 271
Self-citationHuugen, D., van Esch, A., Xiao, H., Peutz-Kootstra, C.-J., Buurman, W.-A., Tervaert, J. W. C., Jennette, J.-C., & Heeringa, P. (2007) · Kidney International · doi:10.1038/sj.ki.5002103 · Cited by 249
Pathogenesis of Antineutrophil Cytoplasmic Autoantibody–Associated Small-Vessel Vasculitis
Jennette, J. C., Falk, R. J., Hu, P., & Xiao, H. (2013) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-011811-132453 · Cited by 243
Complement in Immune and Inflammatory Disorders: Therapeutic Interventions
Ricklin, D., & Lambris, J. D. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1203200 · Cited by 235
Heurich, M., Martínez-Barricarte, R., Francis, N. J., Roberts, D. L., Rodríguez de Córdoba, S., Morgan, B. P., & Harris, C. L. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1019338108 · Cited by 231
Adler, S., Baker, P. J., Johnson, R. J., Ochi, R. F., Pritzl, P., & Couser, W. G. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112372 · Cited by 229
Meri, S., Koistinen, V, Miettinen, A., Törnroth, T., & Seppälä, I. J. (1992) · The Journal of experimental medicine · doi:10.1084/jem.175.4.939 · Cited by 223
C3a and C5a Promote Renal Ischemia-Reperfusion Injury
Peng, Q., Li, K., Smyth, L. A., Xing, G., Wang, N., Meader, L., Lu, B., Sacks, S. H., & Zhou, W. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2011111072 · Cited by 222
Kim, Y. U., Kinoshita, T., Molina, H., Hourcade, D., Seya, T., Wagner, L. M., & Holers, V. M. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.1.151 · Cited by 218
Eculizumab in the Treatment of Membranoproliferative Glomerulonephritis
Bomback, A. S. (2014) · Nephron Clinical Practice · doi:10.1159/000368592 · Cited by 216
Kwan, W.-H., van der Touw, W., Paz-Artal, E., Li, M. O., & Heeger, P. S. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20121525 · Cited by 215 · cited 1×
“Our group showed that peripheral, murine, natural regulatory T cells (nTregs) express C3aR and C5aR and that signaling through these receptors inhibits Treg function (11).”
BackgroundSelf-citationHuman T Cells Express the C5a Receptor and Are Chemoattracted to C5a
Nataf, S., Davoust, N., Ames, R. S., & Barnum, S. R. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.7.4018 · Cited by 214
Sethi, S., Fervenza, F. C., Zhang, Y., Zand, L., Meyer, N. C., Borsa, N., Nasr, S. H., & Smith, R. J. H. (2013) · Kidney International · doi:10.1038/ki.2012.384 · Cited by 208
Licht, C., Heinen, S., Józsi, M., Löschmann, I., Saunders, R. E., Perkins, S. J., Waldherr, R., Skerka, C., Kirschfink, M., Hoppe, B., et al. (2006) · Kidney International · doi:10.1038/sj.ki.5000269 · Cited by 205
Fujita, T., Inoue, T., Ogawa, K., Iida, K., & Tamura, N. (1987) · The Journal of experimental medicine · doi:10.1084/jem.166.5.1221 · Cited by 204
Basic and Translational Concepts of Immune-Mediated Glomerular Diseases
Couser, W. G. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2011030304 · Cited by 202
The role of complement in the early immune response to transplantation
Sacks, S. H., & Zhou, W. (2012) · Nature Reviews Immunology · doi:10.1038/nri3225 · Cited by 197
Local extravascular pool of C3 is a determinant of postischemic acute renal failure
Farrar, C. A., Zhou, W., Lin, T., & Sacks, S. H. (2006) · The FASEB Journal · doi:10.1096/fj.05-4747com · Cited by 195
Brooimans, R. A., Stegmann, A. P., van Dorp, W. T., van der Ark, A. A., van der Woude, F. J., van Es, L. A., & Daha, M. R. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115314 · Cited by 194
Takahashi, M., Takeda, J., Hirose, S., Hyman, R., Inoue, N., Miyata, T., Ueda, E., Kitani, T., Medof, M. E., & Kinoshita, T. (1993) · The Journal of experimental medicine · doi:10.1084/jem.177.2.517 · Cited by 188
Pickering, M. C., & Cook, H. T. (2008) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2007.03574.x · Cited by 185
Influence of Donor C3 Allotype on Late Renal-Transplantation Outcome
Brown, K. M., Kondeatis, E., Vaughan, R. W., Kon, S. P., Farmer, C. K. T., Taylor, J. D., He, X., Johnston, A., Horsfield, C., Janssen, B. J. C., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052825 · Cited by 179
Freitas, M. C. S., Rebellato, L. M., Ozawa, M., Nguyen, A., Sasaki, N., Everly, M., Briley, K. P., Haisch, C. E., Bolin, P., Parker, K., et al. (2013) · Transplantation · doi:10.1097/tp.0b013e3182888db6 · Cited by 178
Salama, A. D., Levy, J. B., Lightstone, L., & Pusey, C. D. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06077-9 · Cited by 175
Compstatin: A Complement Inhibitor on its Way to Clinical Application
Ricklin, D., & Lambris, J. D. (2008) · Advances in experimental medicine and biology · doi:10.1007/978-0-387-78952-1_20 · Cited by 162
Pickering, M. C., Warren, J. A., Rose, K. L., Carlucci, F., Wang, Y., Walport, M. J., Cook, H. T., & Botto, M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601094103 · Cited by 159
C3a Mediates Epithelial-to-Mesenchymal Transition in Proteinuric Nephropathy
Tang, Z., Lu, B., Hatch, E., Sacks, S. H., & Sheerin, N. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008040434 · Cited by 147
Jane-wit, D., Manes, T. D., Yi, T., Qin, L., Clark, P., Kirkiles-Smith, N. C., Abrahimi, P., Devalliere, J., Moeckel, G., Kulkarni, S., et al. (2013) · Circulation · doi:10.1161/circulationaha.113.002972 · Cited by 144
Bao, L., Osawe, I., Puri, T. S., Lambris, J. D., Haas, M., & Quigg, R. J. (2005) · European Journal of Immunology · doi:10.1002/eji.200526327 · Cited by 143
Naesens, M., Li, L., Ying, L., Sansanwal, P., Sigdel, T. K., Hsieh, S., Kambham, N., Lerut, E., Salvatierra, O., Butte, A. J., et al. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008111145 · Cited by 135
Complement Factor H Deficiency Accelerates Development of Lupus Nephritis
Bao, L., Haas, M., & Quigg, R. J. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010060647 · Cited by 132
Monaco, A. P., Burke, J. F., Ferguson, R. M., Halloran, P. F., Kahan, B. D., Light, J. A., Matas, A. J., & Solez, K. (1999) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(99)70273-8 · Cited by 131
Yuan, H., Takeuchi, E., Taylor, G. A., McLaughlin, M. M., Brown, D., & Salant, D. J. (2002) · Journal of the American Society of Nephrology · doi:10.1681/asn.v134946 · Cited by 130
Depletion of C6 prevents development of proteinuria in experimental membranous nephropathy in rats.
Baker, P. J., Ochi, R. F., Schulze, M. B., et al. (1989) · PubMed · Cited by 129
van der Touw, W., Cravedi, P., Kwan, W.-H., Paz‐Artal, E., Mérad, M., & Heeger, P. S. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1300847 · Cited by 127
Self-citationImmune Cell-Derived C3a and C5a Costimulate Human T Cell Alloimmunity
Cravedi, P., Leventhal, J. S., Lakhani, P., Ward, S. C., Donovan, M. J., & Heeger, P. S. (2013) · American Journal of Transplantation · doi:10.1111/ajt.12405 · Cited by 125
Self-citationComplement C5 Mediates Experimental Tubulointerstitial Fibrosis
Boor, P., Konieczny, A., Villa, L., Schult, A. L., Diaeresis]cher, E. B., Rong, S., Kunter, U., van Roeyen, C. R. C., Polakowski, T., Hawlisch, H., et al. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006121343 · Cited by 124
Functional Anatomy of Complement Factor H
Makou, E., Herbert, A. P., & Barlow, P. N. (2013) · Biochemistry · doi:10.1021/bi4003452 · Cited by 121
Activated Human T Lymphocytes Express a Functional C3a Receptor
Werfel, T., Kirchhoff, K., Wittmann, M., Begemann, G., Kapp, A., Heidenreich, F., Götze, O., & Zwirner, J. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.11.6599 · Cited by 117
Complement 5a Receptor Inhibition Improves Renal Allograft Survival
Gueler, F., Rong, S., Gwinner, W., Mengel, M., Bröcker, V., Schön, S., Greten, T. F., Hawlisch, H., Polakowski, T., Schnatbaum, K., et al. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007111267 · Cited by 114
The Development of Atypical Hemolytic Uremic Syndrome Depends on Complement C5
de Jorge, E. G., Macor, P., Paixão-Cavalcante, D., Rose, K. L., Tedesco, F., Cook, H. T., Botto, M., & Pickering, M. C. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010050451 · Cited by 112
Wang, H., Arp, J., Liu, W., Faas, S. J., Jiang, J., Gies, D. R., Ramcharran, S., Garcia, B. M., Zhong, R., & Rother, R. P. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.7.4451 · Cited by 110
Functional modulation of human monocytes derived DCs by anaphylatoxins C3a and C5a
Li, K., Fazekasova, H., Wang, N., Peng, Q., Sacks, S. H., Lombardi, G., & Zhou, W. (2012) · Immunobiology · doi:10.1016/j.imbio.2011.07.033 · Cited by 108
IgM Contributes to Glomerular Injury in FSGS
Strassheim, D., Renner, B., Panzer, S. E., Fuquay, R., Kulik, L. N., Ljubanović, D. G., Holers, V. M., & Thurman, J. M. (2013) · Journal of the American Society of Nephrology · doi:10.1681/asn.2012020187 · Cited by 105
Pavlov, V. I., Raedler, H., Yuan, S., Leisman, S. A., Kwan, W.-H., Lalli, P. N., Medof, M. E., & Heeger, P. S. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.7.4580 · Cited by 99
Self-citationVernon, K. A., de Jorge, E. G., Hall, A. E., Frémeaux‐Bacchi, V., Aitman, T. J., Cook, H. T., Hangartner, R., Koziell, A. B., & Pickering, M. C. (2012) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2012.02.329 · Cited by 98
Patel, H., Smith, R. A., Sacks, S. H., & Zhou, W. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005101116 · Cited by 96
Synthesis of complement protein C3 in the kidney is an important mediator of local tissue injury
Sheerin, N., Risley, P., Abe, K., Tang, Z., Wong, W., Lin, T., & Sacks, S. H. (2007) · The FASEB Journal · doi:10.1096/fj.07-8719com · Cited by 93
Nakorchevsky, A., Hewel, J. A., Kurian, S. M., Mondala, T. S., Campbell, D., Head, S. R., Marsh, C. L., Yates, J. R., & Salomon, D. R. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009060628 · Cited by 81
Hébert, M. J., Takano, T., Papayianni, A., et al. (1998) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/13.11.2799 · Cited by 80
Dense Deposit Disease and C3 Glomerulopathy
Barbour, T., Pickering, M. C., & Cook, H. T. (2013) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2013.08.002 · Cited by 72
Atkinson, C., Qiao, F., Song, H., Gilkeson, G. S., & Tomlinson, S. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.2.1231 · Cited by 71
C3 Polymorphisms and Allograft Outcome in Renal Transplantation
Varagunam, M., Yaqoob, M., Döhler, B., & Opelz, G. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0801861 · Cited by 71
Raedler, H., Yang, M., Lalli, P. N., Medof, M. E., & Heeger, P. S. (2009) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2009.02723.x · Cited by 66
Self-citationParoxysmal Nocturnal Hemoglobinuria — Hemolysis before and after Eculizumab
Risitano, A. M., Notaro, R., Luzzatto, L., Hill, A., Kelly, R., & Hillmen, P. (2010) · New England Journal of Medicine · doi:10.1056/nejmc1010351 · Cited by 65
Complement Regulates CD4 T-Cell Help to CD8 T Cells Required for Murine Allograft Rejection
Vieyra, M. B., Leisman, S. A., Raedler, H., Kwan, W.-H., Yang, M., Strainic, M. G., Medof, M. E., & Heeger, P. S. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.04.038 · Cited by 60
Self-citationC3a is made by proximal tubular HK-2 cells and activates them via the C3a receptor
Peake, P. W., O'Grady, S. E., Pussell, B. A., & CHARLESWORTH, J. A. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00722.x · Cited by 55
Ma, R., Cui, Z., Hu, S., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0091250 · Cited by 49
Raedler, H., Vieyra, M. B., Leisman, S. A., Lakhani, P., Kwan, W., Yang, M., Johnson, K. K., Faas, S. J., Tamburini, P. P., & Heeger, P. S. (2011) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2011.03561.x · Cited by 47
Self-citationExpression of the anaphylatoxin C5a receptor in the oligodendrocyte lineage
Nataf, S., Levison, S. W., & Barnum, S. R. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02003-0 · Cited by 46
Sethi, S. M., Fervenza, F. C., Zhang, Y., & Smith, R. J. (2012) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2012.04.011 · Cited by 37
Decay Accelerating Factor is Essential for Successful Corneal Engraftment
Esposito, A., Suedekum, B., Liu, J., An, F., Lass, J. H., Strainic, M. G., Lin, F., Heeger, P. S., & Medof, M. E. (2010) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2009.02961.x · Cited by 25
Self-citationAssociation of complement 5 genetic polymorphism with renal allograft outcomes in Korea
Jeong, J. C., Hwang, Y., Kim, H., Ro, H., Park, H. C., Kim, Y. J., Kim, M.-G., Ha, J., Park, M. H., Chae, D., et al. (2011) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfr025 · Cited by 22
Complement Component C3 Secretion by Mouse Macrophage-Like Cell Lines
Goodrum, K. J. (1987) · Journal of Leukocyte Biology · doi:10.1002/jlb.41.4.295 · Cited by 20
Finke, D., Randers, K., Hoerster, R., Hennig, H., Zawatzky, R., Marion, T. N., Brockmann, C., Klempt‐Giessing, K., Jacobsen, K., Kirchner, H., et al. (2007) · European Journal of Immunology · doi:10.1002/eji.200636719 · Cited by 15
Cited by
COVID-19: what has been learned and to be learned about the novel coronavirus disease
Yi, Y., Lagniton, P. N. P., Ye, S., Li, E., & Xu, R.-H. (2020) · International Journal of Biological Sciences · doi:10.7150/ijbs.45134 · Cited by 832
Complement Activation Contributes to Severe Acute Respiratory Syndrome Coronavirus Pathogenesis
Gralinski, L. E., Sheahan, T. P., Morrison, T. E., Menachery, V. D., Jensen, K., Leist, S. R., Whitmore, A., Heise, M. T., & Baric, R. S. (2018) · mBio · doi:10.1128/mbio.01753-18 · Cited by 655
Kirtipal, N., Bharadwaj, S., & Kang, S. G. (2020) · Infection, Genetics and Evolution · doi:10.1016/j.meegid.2020.104502 · Cited by 306
The next generation of therapeutics for chronic kidney disease
Breyer, M. D., & Susztak, K. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.67 · Cited by 272
Winthrop, K. L., Mariette, X., Silva, J. T., Benamu, E., Calabrese, L. H., Dumusc, A., Smolen, J. S., Aguado, J. M., & Fernández-Ruiz, M. (2018) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2018.02.002 · Cited by 259
Metadata
- Authors
- Mathern, D. R., & Heeger, P. S.
- Venue
- Clinical Journal of the American Society of Nephrology
- Published
- 2015-09
- Volume
- 10
- Issue
- 9
- Pages
- 1636-1650
- ISSN
- 1555-9041 (ISSN-L)
- OpenAlex
- W2113036981
- Cited by
- 290
- References
- 108
- FWCI
- 10.72
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.